Ceftizoxime
General information:
| Withdrawn ID: | 1032 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | J01DD07 |
| Molecular Formula: | C13H13N5O5S2 |
| Molweight: | 383.403 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1983 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Ceftizoxime as primary suspect: | 6 |
|---|
Reported final outcomes:
| Life-Threatening condition: | 4 |
|---|---|
| Death: | 1 |
Reported side-effects:
| Side-effect | Case number |
|---|---|
| PYREXIA | 4 |
| PHARMACEUTICAL PRODUCT COMPLAINT | 4 |
| CHILLS | 4 |
| RASH | 1 |
| ISOIMMUNE HAEMOLYTIC DISEASE | 1 |
| CONTINUOUS HAEMODIAFILTRATION | 1 |
Toxicity information:
| Toxicity class: | 6 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 10000 mg/kg |
External links:
| ChEBML: | CHEMBL528 |
|---|---|
| DrugBank: | DB01332 |